Patents by Inventor Frank Ridder

Frank Ridder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110009268
    Abstract: The novel process for coacervating iodopropargyl compounds affords stable aqueous dispersions of coacervated iodopropargyl compounds which, optionally in a mixture with further active biocidal ingredients, can be used very effectively to protect technical materials.
    Type: Application
    Filed: January 23, 2008
    Publication date: January 13, 2011
    Inventors: Hermann Uhr, Daniel Rudhardt, Frank Ridder, Johan Kijstra, Sascha Plug
  • Publication number: 20090269411
    Abstract: Taste-masked powders that can be inhaled or administered orally, a simple method for the production thereof, and the use thereof for applying biologically active substances.
    Type: Application
    Filed: December 20, 2006
    Publication date: October 29, 2009
    Applicant: Bayer Technology Services GmbH
    Inventors: Rainer Bellinghausen, Daniel Rudhardt, Frank Ridder, Martin Steinbeck, Jesko Zank, Martin Weiss, Olaf Behrend, Udo Van Stiphout
  • Publication number: 20070104795
    Abstract: The invention relates to a formulation having a plurality of phases containing active ingredients. Said formulation is characterised in that: it contains a first, innermost, finely distributed phase (I) consisting of active ingredients or an active ingredient solution, preferably some of the phase particles being surrounded by a barrier sheath (M); the formulation has a second, intermediate phase (II) that serves as a dispersant for the first, inner phase (I) and can also be dissolved in the active ingredient; and the formulation has a third, outer phase (III) that serves as a dispersant for the second intermediate phase and can, in turn, be dissolved in the active ingredient and/or can be in the form of solid particles that can, in turn, be surrounded by a barrier sheath. In this way, a plurality of biological active ingredients can be produced in the different phases in different concentrations and with a respectively controlled release rate in a single formulation.
    Type: Application
    Filed: December 15, 2004
    Publication date: May 10, 2007
    Applicant: Bayer Technology Services GmbH
    Inventors: Daniel Rudhardt, Frank Ridder, Stefan Hofmann